Clinical Evidence and Safety Profile of Emicizumab for the Management of Children with Hemophilia A
Sandra Le Quellec1,2 1Unité d’hémostase Clinique – Hôpital Cardiologique Louis Pradel – Hospices Civils de Lyon, Lyon, France; 2Service d’hématologie biologique, Groupement Hospitalier Est – Hospices Civils...
Saved in:
Main Author: | Le Quellec S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emicizumab in the treatment of hemophilia A
by: Tijanić Ivan R., et al.
Published: (2020) -
Management of children with hemophilia A on emicizumab who need surgery
by: Mark Belletrutti, et al.
Published: (2023) -
THE USE OF EMICIZUMAB IN A CHILD WITH HEMOPHILIA A INHIBITORY FOREMA
by: Юлия Олеговна Рождественская, et al.
Published: (2023) -
Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
by: Linari S, et al.
Published: (2020) -
Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective
by: Ricardo Mesquita Camelo, et al.
Published: (2023)